We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors

By HospiMedica International staff writers
Posted on 02 Sep 2009
Stereotactic body radiotherapy (SBRT) has been shown to be a highly effective alternative treatment for some cancer patients with spinal metastases, according to a new study.

"These data confirm the established method of cancer treatment used on spinal tumors and other hard to reach areas of the body, due to the precisely targeted radiation dose and noninvasive nature of radiosurgery,” said James G. More...
Schwade, M.D., from the University of Texas in Houston (USA), and executive director of the CyberKnife Centers of Miami and Palm Beach, FL, USA.

Dr. Schwade's study was presented at the American Association of Neurological Surgeons annual meeting in San Diego, CA, USA, in August 2009. "SBRT offers patients a minimally invasive treatment option they previously did not have,” said Dr. Eric L. Chang. "We are also able to offer patients a degree of pain control and to decrease their pain medications, minimizing the side effects from those medications.”

In the study, researchers evaluated 121 cancer patients with metastases to the spine who underwent intensity-modulated, near simultaneous, computed tomography (CT) image-guided SBRT, according to Dr. Chang. Researchers used a stereotactic body frame system consisting of a whole-body vacuum cushion and plastic fixation sheet used to immobilize patients for the treatment period, which lasts approximately one hour.

The team performed magnetic resonance (MR) imaging of the spine within 30 days of patient enrollment, every three months for the first year, and every six months after that. Patients also evaluated their own pain and other discomfort using instruments including the validated Brief Pain Inventory and the M.D. Anderson [Houston, TX, USA] Symptom Inventory.

Related Links:
University of Texas in Houston





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Hybrid Arch Device
Neo EDE
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.